Lannett Company Inc. has recalled 46,848 bottles of Niacin (nicotinic acid) 1,000 mg Extended-release Tablets because the medication failed dissolution specifications. This means the tablets may not break down or release the medication at the proper rate, which can affect how the drug is absorbed into the body. These prescription tablets were distributed nationwide in 90-count bottles and were manufactured in the United States.
If the tablets do not dissolve correctly, the medication may be released too slowly or too quickly, potentially leading to ineffective treatment of high cholesterol or unexpected side effects from incorrect dosing levels.
You have 2 options:
Recall #: D-0096-2026; Distributed by Lannett Company, Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.